Skip to main content
Clinical Trials/NCT01815814
NCT01815814
Completed
Not Applicable

Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy

Stanford University1 site in 1 country38 target enrollmentStarted: November 2011Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
38
Locations
1
Primary Endpoint
Change in Gross Motor Function Measure Score

Overview

Brief Summary

The investigators hypothesize that children with spastic cerebral palsy will show greater improvements in gross motor function, associated developmental skills and growth after the 3 months of myofascial structural integration treatment, a form of deep massage, than they showed after a 3- or 6-month pre-treatment waiting period.

The investigators further hypothesize that children with spastic CP will maintain their gains in gross motor function for ≥ 3 months after completion of MSI treatment.

Detailed Description

  • The investigators will talk to you by telephone to determine if your child is eligible for the study.
  • The study lasts for a total of 12 months with the massage treatment period lasting 12 weeks.
  • The study entails a total of 10 sessions of Myofascial Structural Integration therapy over the 12-week period. Each session will last one hour.
  • The child will have an evaluation of motor functions and development on enrollment and at three-month intervals for a total of 5 evaluations.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
1 Year to 3 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Children from 1 up to, but not including, 7 years of age
  • Children having the diagnosis of spastic cerebral palsy
  • Children who have spasticity in one or both upper or lower limbs
  • Children who are classified as either Gross Motor Function Classification System (GMFCS) level 2, 3 or 4 or Manual Ability Classification System (MACS) level 2, 3, 4 or 5

Exclusion Criteria

  • Children with active seizure disorders
  • Children taking more than one medication to control their seizures
  • Children with severe health problems that could be exacerbated by the treatment (such as severe chronic lung disease)
  • Children who have undergone surgical treatments or botulinum injections within 6 months of entering the study
  • Children who have planned surgical interventions during the studies time course
  • Children with sensory, cognitive or language deficits which would affect their ability to understand directions necessary for assessment.

Outcomes

Primary Outcomes

Change in Gross Motor Function Measure Score

Time Frame: at Enrollment and every 3 months thereafter for up to 12 months

Secondary Outcomes

  • Change in GAITRite Mat Measures(at Enrollment and every 3 months thereafter for up to 12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Heidi M. Feldman

Ballinger-Swindells Professor of Developmental and Behavioral Pediatrics

Stanford University

Study Sites (1)

Loading locations...

Similar Trials